Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.
NMI | BE
Overview
Corporate Details
- ISIN(s):
- DE000A12ULL2
- LEI:
- 391200M0N1PWTP19RE15
- Country:
- Germany
- Address:
- Unter den Linden 10, 10117 Berlin
- Website:
- https://aladdinid.com/
Description
Aladdin Healthcare Technologies SE is a healthcare technology company that leverages artificial intelligence for drug discovery and diagnostics. The company's primary focus is on developing solutions for age-related conditions, with a significant emphasis on Alzheimer's disease. It utilizes a proprietary AI platform for virtual screening to identify novel small molecule drug compounds. In addition to drug development, the company develops AI-powered diagnostic tools and health screening services, which include applications for advanced image processing and analysis.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-08-31 08:00 |
Aladdin Healthcare Technologies achieves OTCQX listing in the USA
|
English | 9.3 KB | ||
| 2020-07-30 09:31 |
Aladdin Healthcare Technologies validates its proprietary Deep Learning Algorit…
|
English | 11.8 KB | ||
| 2020-07-28 09:00 |
Aladdin Healthcare Technologies becomes a sponsor of University College London'…
|
English | 9.9 KB | ||
| 2020-07-20 08:00 |
Aladdin Healthcare Technologies develops fully automated deep learning process …
|
English | 10.7 KB | ||
| 2020-07-02 09:57 |
Aladdin Healthcare Technologies SE discovers Life-Saving Drug Repurposed for Co…
|
English | 11.6 KB | ||
| 2020-06-17 09:01 |
Aladdin Healthcare Technologies SE takes another big step forward in early diag…
|
English | 11.6 KB | ||
| 2020-05-27 12:09 | English | 14.2 KB | |||
| 2020-05-22 13:20 | English | 14.2 KB | |||
| 2020-05-20 08:00 |
Aladdin Healthcare Technologies SE achieves further milestone in COVID-19 drug …
|
English | 10.5 KB | ||
| 2020-05-18 12:41 |
Release according to Article 41 of the WpHG [the German Securities Trading Act]…
|
English | 4.3 KB | ||
| 2020-05-14 09:00 |
Aladdin Healthcare Technologies SE wins EUR 1.4 million EU grant with large-sca…
|
English | 10.7 KB | ||
| 2020-04-30 08:00 |
Aladdin Healthcare Technologies SE promotes drug development with Joint Venture…
|
English | 9.6 KB | ||
| 2020-04-29 12:45 |
Aladdin Healthcare Technologies sets up Joint Venture with Chinese partner netw…
|
English | 6.6 KB | ||
| 2020-04-28 16:22 |
Aladdin Healthcare Technologies SE: Verzogerung bei der Veroffentlichung des Ja…
|
German | 6.7 KB | ||
| 2020-04-16 09:00 |
Aladdin Healthcare Technologies SE has launched its Health Risk Assessment Tool…
|
English | 12.0 KB |
Automate Your Workflow. Get a real-time feed of all Aladdin Healthcare Technologies SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Aladdin Healthcare Technologies SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Aladdin Healthcare Technologies SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-02-02 | Menpes-Smith, Mr Wade | Board | Other | None | 211,425.00 EUR |
| 2021-09-21 | Continental Aktiengesellschaft | Close relation | Sell | None | 243,288.00 EUR |
| 2021-09-20 | Smith, Wade | Board | Other | None | 211,425.00 EUR |
Peer Companies
